Detection chip for detecting male malignant tumor marker, and production method and application thereof
A malignant tumor and detection chip technology, which is applied in the direction of measuring devices, instruments, scientific instruments, etc., can solve problems such as functional differences, and achieve the effects of preventing false positives, eliminating non-specific adsorption, and low background value
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0034] 1. Experiment setup method
[0035] The tested antibodies used in this example are shown in Table 1, and the suppliers involved are as follows: Guangzhou Ruiboao Biotechnology Co., Ltd. (Ruiboao), Santa Cruz Biotechnology (Santa Cruz), Thermo Fisher Technology (invitrogen), Novus Biologicals (Novusbio), Faipeng Biological Co., Ltd. (Fepeng), RDBiosciences (RD), Shanghai Yiji Industrial Co., Ltd. Le), Nanjing Oukai Biotechnology Co., Ltd. (Oukai), OriGene Technologies (Origene), GenScript Biotechnology Co., Ltd. (GenScript), Parker Bio (Parker). At 37°C, using Thermo Scientific TM Wellwash TM The plate washer was used to make the tested antibodies react with AFP, CA125, TG, CA199, CA724, CEA, fPSA, tPSA, NSE, PGI, PGII, and SCCA1 to carry out the matching test of the tested antibodies and antigens.
[0036] The experimental parameters of the paired detection experiment are: carrier, 96 microwell plate; antigen diluent, PBS; blocking solution, 5% skimmed milk powder +...
Embodiment 2
[0086] 1. Test antibody
[0087] Select the following antibodies in Example 1 as the test antibody of this example:
[0088] The first AFP antibody, the third AFP antibody, the sixth AFP antibody;
[0089] the second CA125 antibody, the third CA125 antibody, the sixth CA125 antibody;
[0090] The second TG antibody, the fourth TG antibody, the fifth TG antibody;
[0091] The first CEA antibody, the fourth CEA antibody;
[0092] Second fPSA antibody, fourth fPSA antibody, fifth fPSA antibody, seventh fPSA antibody;
[0093] Second tPSA antibody, fifth tPSA antibody;
[0094] The second NSE antibody, the fourth NSE antibody, the fifth NSE antibody;
[0095] The first PGI antibody, the third PGI antibody;
[0096] The first PGII antibody, the second PGII antibody, the third PGII antibody, the fifth PGII antibody;
[0097] First SCCA1 antibody, second SCCA1 antibody, fourth SCCA1 antibody, sixth SCCA1 antibody.
[0098] 2. Experiment setting method
[0099] The test antib...
Embodiment 3
[0126] 1. Experiment setup method
[0127] In this example, the solid-phase carrier of the chip for preparing the capture antibody mixture is used as a variable to set up two treatment groups. The chip is used as the solid phase carrier of the chip.
[0128] The primary antibody combinations used in this example are those in Example 1: the third AFP antibody, the sixth CA125 antibody, the fifth TG antibody, the first CEA antibody, the first CA199 antibody, the first CA724 antibody, the seventh fPSA antibody, Fifth tPSA antibody, second tPSA antibody, second NSE antibody, third PGI antibody, first PGII antibody, and second SCCA1 antibody.
[0129] The secondary antibody combinations used in this example are those in Example 1: the first AFP antibody, the second CA125 antibody, the fourth TG antibody, the fourth CEA antibody, the second CA199 antibody, the second CA724 antibody, the fifth fPSA antibody, Second tPSA antibody, fifth tPSA antibody, fourth NSE antibody, first PGI ...
PUM
| Property | Measurement | Unit |
|---|---|---|
| Sensitivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


